Kisqali Femara Co-Pack Coupon & Prices

Your monthly Kisqali Femara Co-Pack cost savings if eligible

If you are eligible for the Kisqali Femara Co-Pack patient assistance program, the cost of your medication will be free. We only charge $49 per month for each medication, to cover our service fees. You could receive your Kisqali Femara Co-Pack prescription for just $49 a month, regardless of the retail price of your medication.

Am I eligible for the Kisqali Femara Co-Pack patient assistance program?

We will review your application to determine whether you are eligible for the Kisqali Femara Co-Pack patient assistance program. Each program has its own eligibility criteria which are set by the pharmaceutical companies, however the factors considered by most programs are:

• I am a permanent, legal resident of the United States or Puerto Rico
• I am uninsured or my insurance doesn’t cover my medication
• I meet certain income eligibility requirements

How do I apply for the Kisqali Femara Co-Pack patient assistance program?

We make it as easy as possible to apply for the Kisqali Femara Co-Pack patient assistance program. The first step is to complete our enrollment application. Tell us about any medications you are taking, including Kisqali Femara Co-Pack. We will also ask for details about your healthcare provider, insurance, and your household income. This information is required by the pharmaceutical manufacturers who ship your medication.

If we determine that you may be eligible for Kisqali Femara Co-Pack assistance, we will handle the application process for you. We will work directly with your healthcare provider to prepare your application documents. Once we have received the signed application and supporting documents, we will submit them to the patient assistance program on your behalf. Our service continues once you are enrolled in the Kisqali Femara Co-Pack patient assistance program, and we will automatically request your Kisqali Femara Co-Pack medication refills for up to 1 year.

Is NiceRx a Kisqali Femara Co-Pack coupon provider?

We are a service provider that helps eligible individuals access the Kisqali Femara Co-Pack patient assistance program. That means that we do not offer printable Kisqali Femara Co-Pack manufacturer coupons, Kisqali Femara Co-Pack discounts, or free Kisqali Femara Co-Pack samples. We are not a Kisqali Femara Co-Pack coupon provider or Kisqali Femara Co-Pack discount card. Our service extends to assisting eligible individuals to access the medications they need through patient assistance programs.

Can NiceRx help me get Kisqali Femara Co-Pack cheaper if I have insurance?

We may be able to help you to access Kisqali Femara Co-Pack patient assistance in a variety of circumstances. This includes when your insurance company will not pay for your Kisqali Femara Co-Pack medication or if you have a high copay or coinsurance responsibility. We may also be able to help you if you do not have insurance. Please apply online to find out more.

How much does Kisqali Femara Co-Pack cost without insurance?

Kisqali Femara Co-Pack cost without insurance will vary depending on where you buy it. As a guide, Kisqali Femara Co-Pack oral tablets (2.5 mg-200 mg) usually cost $6,400 for 49 tablets. With NiceRx you will pay a flat monthly fee of $49, regardless of the retail price of your medication.

How much does Kisqali Femara Co-Pack cost with insurance?

The copay for Kisqali Femara Co-Pack with insurance depends on the terms of your healthcare plan. To find out how much this is, your healthcare provider or pharmacist will be able to calculate your copay with your current insurance.

What is Kisqali Femara Co-Pack?

Kisqali Femara Co-Pack is an FDA (U.S. Food and Drug Administration) approved medication manufactured by Novartis Pharmaceuticals Corporation. Kisqali Femara Co-Pack, contains ribociclib, a kinase inhibitor, and letrozole, an aromatase inhibitor. It is used as an initial endocrine-based treatment of pre/perimenopausal or postmenopausal women with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer.

It is also used with fulvestrant as initial endocrine-based therapy or after disease progression on endocrine therapy to treat postmenopausal women with HR-positive, HER2-negative advanced breast cancer.

What doses of Kisqali Femara Co-Pack are available?

Kisqali Femara Co-Pack is available in tablet form, in the following doses: Kisqali 200 mg, Femara 2.5 mg.

Kisqali Femara Co-Pack tablets are taken orally with or without food. The recommended starting daily dose of Kisqali is 600 mg once daily for 21 days followed by 7 days off Kisqali treatment. Take Femara as one 2.5 mg tablet continuously for a 28-day cycle.

Low levels of potassium or magnesium in your blood may increase your risk of QT prolongation. This risk may be further exacerbated if you use certain drugs, such as diuretics or if you have severe sweating, diarrhea, or vomiting.

Please read the full prescribing information and always speak with your healthcare provider about any changes to your dose so they can monitor and evaluate your condition.

Kisqali Femara Co-Pack active ingredients

Kisqali Femara Co-Pack contains ribociclib tablets and letrozole tablets as the active ingredients.

Kisqali Femara Co-Pack side effects

The most common side effects of Kisqali Femara Co-Pack in clinical trials compared to placebo include:

• Neutropenia, leukopenia, anemia
• Nausea, vomiting
• Infections
• Tiredness
• Diarrhea, constipation, loss of appetite
• Alopecia (hair loss)
• Headache, back pain
• Rash

In rare instances, Kisqali Femara Co-Pack can cause more serious side effects. These can include:

• Interstitial lung disease (ILD)/Pneumonitis – patients treated with CDK 4/6 inhibitors (Kisqali) should be monitored for pulmonary symptoms
• Severe cutaneous adverse reactions
• QT interval prolongation – monitor electrocardiograms (ECGs) and electrolytes before starting treatment
• Hepatobiliary toxicity – perform liver function tests before starting treatment
• Neutropenia – perform a complete blood count (CBC) before starting treatment
• Embryo-fetal toxicity

Your doctor will assess the benefits of using Kisqali Femara Co-Pack against your risk of side effects. Patients are encouraged to report negative side effects or adverse reactions of Kisqali Femara Co-Pack to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Kisqali Femara Co-Pack drug interactions

Kisqali Femara Co-Pack can interact with other medications. These include:

• Strong CYP3A inhibitors
• Strong CYP3A inducers
• Drugs known to prolong QT interval – amiodarone, dronedarone, pimozide, ondansetron
• Estrogens (such as estradiol), tamoxifen, and tibolone
• Rifamycins – rifampin, rifabutin
• St. John’s wort
• Drugs used to treat seizures – carbamazepine, and phenytoin
• Ergot alkaloids – ergotamine
• Avoid eating grapefruit or drinking grapefruit juice

This list is not exhaustive and other prescription drugs may interact with Kisqali Femara Co-Pack.

Kisqali Femara Co-Pack contraindications

You should not use Kisqali Femara Co-Pack if you:

• Are allergic to the active ingredients ribociclib or letrozole
• Are allergic to any of the other ingredients in Kisqali Femara Co-Pack
• Are pregnant or are planning to become pregnant – use effective contraception during therapy with Kisqali Femara Co-Pack and for at least 3 weeks after the last dose

Talk to your doctor before using Kisqali Femara Co-Pack if you:

• Are taking any of the medications that could interact with Kisqali Femara Co-Pack
• Are breastfeeding or are planning to breastfeed

Kisqali Femara Co-Pack generic

Kisqali Femara Co-Pack is the trademark brand name for ribociclib and letrozole manufactured by Novartis Pharmaceuticals Corporation. A generic version of ribociclib and letrozole is not available. Generic drugs are generally cheaper than brand-name drugs, but you can still find Kisqali Femara Co-Pack savings through NiceRx.